| Literature DB >> 28161817 |
Yuki Nakamura1, Koichi Toda1, Teruya Nakamura1, Shigeru Miyagawa1, Yasushi Yoshikawa1, Satsuki Fukushima1, Shunsuke Saito1, Daisuke Yoshioka1, Keitaro Domae1, Tsuyoshi Takahashi2, Tadayoshi Hashimoto2, Yuichiro Doki2, Yoshiki Sawa3.
Abstract
The number of patients with end-stage heart failure treated by a left ventricular assist device (LVAD) is dramatically increasing, because the LVAD has been widely accepted for its clinical results. According to the initiation of destination therapy, the prevalence of malignancy in patients with an LVAD is estimated to increase. In patients with LVADs, abdominal surgery for visceral malignancy is associated with technical difficulties because of the presence of an LVAD pump or the driveline which is located transversely in the preperitoneal space. Herein, we describe the technical management for complete resection of gastric cancer in a patient with an LVAD.Entities:
Keywords: Abdominal surgery; Ventricular assist device; Visceral malignancy
Mesh：
Year: 2017 PMID： 28161817 DOI： 10.1007/s10047-016-0944-3
Source DB: PubMed Journal: J Artif Organs ISSN： 1434-7229 Impact factor: 1.731